Literature DB >> 8042045

Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary.

J A Ajani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8042045

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  10 in total

1.  Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma.

Authors:  Min-Young Lee; Ki Sun Jung; Hae Su Kim; Ji Yun Lee; Sung Hee Lim; Moonjin Kim; Hyun Ae Jung; Sung Min Kim; Jong Mu Sun; Myung-Ju Ahn; Jeeyun Lee; Se Hoon Park; Seong Yoon Yi; In Gyu Hwang; Sang-Cheol Lee; Hee Kyung Ahn; Do Hyoung Lim; Soon Il Lee; Keon Woo Park
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.

Authors:  Elisabeth I Heath; Susan Urba; John Marshall; Steven Piantadosi; Arlene A Forastiere
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

3.  Phase II trial of chemotherapy, external and intraluminal radiation plus surgery for oesophageal cancer.

Authors:  J J Beitler; S Wadler; H Haynes; S Fell; A Rozenblit; E Wolf; B A Levine
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

4.  Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.

Authors:  Joanne F Rossman; Carla I Falkson; Ronghui Xu; Coenraad F Slabber; Bernard A Mason; Mary F Mulcahy; Al B Benson
Journal:  Gastrointest Cancer Res       Date:  2011-01

Review 5.  Combined modality therapy for esophageal cancer.

Authors:  Z Gamliel; M J Krasna
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

6.  Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer.

Authors:  J Millar; P Scullin; A Morrison; B McClory; L Wall; D Cameron; H Philips; A Price; D Dunlop; M Eatock
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

7.  Second-line docetaxel-based chemotherapy after failure of fluorouracil-based first-line treatment for advanced esophageal squamous cell carcinoma.

Authors:  Zhengbo Song; Yiping Zhang
Journal:  Onco Targets Ther       Date:  2014-10-13       Impact factor: 4.147

8.  Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Authors:  T C Kok; A Van der Gaast; J Dees; W M Eykenboom; H Van Overhagen; G Stoter; H W Tilanus; T A Splinter
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

9.  Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer.

Authors:  S Petrasch; A Welt; A Reinacher; U Graeven; M König; W Schmiegel
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

Review 10.  Diagnosis and treatment of esophageal neoplasms.

Authors:  H Kato
Journal:  Jpn J Cancer Res       Date:  1995-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.